IPMN
Conditions
Interventions
None listed
Sponsors
Kogure Hirofumi
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are 18 years of age or older at the time of obtaining consent 2) Patients who have been diagnosed with IPMN or diabetes 3) Patients who have been fully informed of the study and have given their written consent freely and of their own accord after fully understanding the contents of the study
Exclusion criteria
Exclusion criteria: 1) Patients who the principal investigator deems unsuitable as research subjects 2) Patients who have refused to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of pancreatic cancer in patients with diabetes-related IPMN during the 3 years following registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Pancreatic cancer incidence in IPMN or diabetes patients during the 3 years after registration Risk factors for pancreatic cancer Fatty pancreas and pancreatic cancer incidence Gastrointestinal cancer incidence in diabetes patients during the 3 years after registration Changes in PDFF due to diabetes treatment Diagnostic accuracy of MRI for fatty pancreas when abdominal ultrasound is used as a surrogate marker10) Tumor markers and positive predictive value for pancreatic cancer | — |
Contacts
Public ContactKei Saito
Nihon University School of Medicine
Outcome results
None listed